3 completed, 1 recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Recruiting 1 |
Follow tivozanib: new trials by email Literature Review of tivozanib trials Research Report on tivozanib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer Pembrolizumab, Tivozanib, Biospecimen Collection - Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC) | Phase 3 | Recruiting | Alliance for Clinical Trials in Oncology | 1040 | 2025-03-14 | 2026-09-02 |
| Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma Tivozanib, Nivolumab - Renal Cell Carcinoma | Phase 3 | Completed | AVEO Pharmaceuticals, Inc. | 343 | 2021-09-09 | 2026-05-08 |
| An Extension Treatment Protocol for Subjects Who Have Participated in a Study of Tivozanib Versus Sorafenib in Kidney Carcinoma (Protocol AV-951-09-301). Tivozanib, Sorafenib - Advanced Renal Cell Carcinoma | Phase 3 | Completed | AVEO Pharmaceuticals, Inc. | 277 | 2010-03-01 | 2020-10-05 |
| A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma tivozanib (AV-951), Sorafenib - Advanced Renal Cell Carcinoma | Phase 3 | Completed | AVEO Pharmaceuticals, Inc. | 517 | 2009-12-01 | 2019-10-28 |
Carcinoma, Renal Cell (2) · Disease Progression (1)
AVEO Pharmaceuticals, Inc. (3) · Alliance for Clinical Trials in Oncology (1)
United States (4) · Canada (3) · Chile (3) · Czechia (3) · France (3) · Italy (3) · Poland (3) · United Kingdom (3) · Argentina (2) · Bulgaria (2) · Hungary (2) · India (2) · Romania (2) · Russia (2) · Serbia (2)
PMID 35304832, PMID 37146227, PMID 39284329
2009 (1)